AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the ...

The US FDA has granted breakthrough device designation to Roche's companion diagnostic VENTANA TROP2 (EPR20043) RxDx Device.

AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

Europe is putting its "ability to protect the health of its own people at risk", the CEO of FTSE 100 giant Astrazeneca has ...

RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment. The device uses artificial intelligence-based ...

Trump's 100th Day, April Jobs Report, Inflation Data, First Quarter GDP, Earnings from Microsoft, Meta Platforms, Apple, ...

Iphone sales have underwhelmed in the US. · PUNIT PARANJPE via Getty Images She said that full-year revenue expectations for Apple were edging lower, "given the upset US trade policy is provoking." ...

When Edward Sheldon asked the generative AI app for the best stocks to buy amid the market pullback, he was presented with ...

Drugmaker AstraZeneca has teamed up with Indian digital ... The aim of the pilot is to scan and review more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance ...